Polyhedral microcrystals encapsulating bone morphogenetic protein 2 improve healing in the alveolar ridge

Journal of Biomaterials Applications

Volumn 30, Issue 2, 2015, Pages 193-200

  Matsumoto, Goichi ^a,d   Ueda, Takayo ^b   Sugita, Yoshihiko ^c   Kubo, Katsutoshi ^c   Mizoguchi, Megumi ^b   Kotani, Eiji ^b   Oda, Naoki ^b   Kawamata, Shin ^e   Segami, Natsuki ^d   Mori, Hajime ^b  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

alveolar ridge; atelocollagen sponge; BMP 2; bone regeneration; polyhedra

Indexed keywords

DEFECTS; GEOMETRY; MICROCRYSTALS; PROTEINS; TISSUE REGENERATION;

ALVEOLAR RIDGE; ATELOCOLLAGEN; BMP-2; BONE REGENERATION; POLYHEDRA;

COMPUTERIZED TOMOGRAPHY;

ATELOCOLLAGEN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN;

ALVEOLAR RIDGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAGLE; BONE DEFECT; BONE DENSITY; BONE REGENERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRYSTAL; ENCAPSULATION; FEMALE; HEALING; HISTOLOGY; MANDIBLE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; POLYHEDRAL MICROCRYSTAL; PRIORITY JOURNAL; ALVEOLAR BONE; ANIMAL; CHEMISTRY; CRYSTALLIZATION; DOG; PATHOLOGY; WOUND HEALING;

ALVEOLAR PROCESS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CRYSTALLIZATION; DOGS; FEMALE; RECOMBINANT PROTEINS; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84936889019     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328215575763     Document Type: Article

References (36)

1. Petite H, Viateau V, Bensaid W,. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959-963.
2. Reddi AH,. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem 1994; 56: 192-195.
3. Reddi AH,. BMPs: actions in flesh and bone. Nat Med 1997; 3: 837-839.
4. Schmitt JM, Hwang K, Winn SR,. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 1999; 17: 269-278.
5. Fiedler J, Roderer G, Gunther KP,. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002; 87: 305-312.
6. Mont MA, Ragland PS, Biggins B,. Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J Bone Joint Surg Am 2004; 86-A: 41-55.
7. Bishop GB, Einhorn TA,. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 2007; 31: 721-727.
8. Carragee EJ, Hurwitz EL, Weiner BK,. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011; 11: 471-491.
9. Koo KH, Yeo do H, Ahn JM,. Lumbar posterolateral fusion using heparin-conjugated fibrin for sustained delivery of bone morphogenic protein-2 in a rabbit model. Artif Organs 2012; 36: 629-634.
10. La WG, Kang SW, Yang HS,. The efficacy of bone morphogenetic protein-2 depends on its mode of delivery. Artif Organs 2010; 34: 1150-1153.
11. Singh K, Smucker JD, Ugbo JL,. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin. Spine J 2007; 7: 326-331.
12. Vaccaro AR, Whang PG, Patel T,. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 2008; 8: 457-465.
13. Jeppsson C, Bostrom M, Aspenberg P,. Intraosseous BMP implants in rabbits. Inhibitory effect on bone formation. Acta Orthop Scand 1999; 70: 77-83.
14. Zabka AG, Pluhar GE, Edwards RB, 3rd,. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. J Orthop Res 2001; 19: 318-327.
15. Meikle MC,. On the transplantation, regeneration and induction of bone: the path to bone morphogenetic proteins and other skeletal growth factors. Surgeon 2007; 5: 232-243.
16. Hsu WK, Wang JC,. The use of bone morphogenetic protein in spine fusion. Spine J 2008; 8: 419-425.
17. Rohrmann GF,. Polyhedrin structure. J Gen Virol 1986; 67: 1499-1513.
18. Matsumoto G, Ueda T, Shimoyama J,. Bone regeneration by polyhedral microcrystals from silkworm virus. Sci Rep 2012; 2: 935-935.
19. Choi Y, Yun JH, Kim CS,. Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis. Clin Oral Implants Res 2011; 23: 682-689.
20. Lee J, Susin C, Rodriguez NA,. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts. Clin Oral Imp Res 2012; 24: 497-504.
21. Benglis D, Wang MY, Levi AD,. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008; 62: ONS423-431. discussion ONS431.
22. Cahill KS, Chi JH, Day A,. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009; 302: 58-66.
23. Paramore CG, Lauryssen C, Rauzzino MJ,. The safety of OP-1 for lumbar fusion with decompression-a canine study. Neurosurgery 1999; 44: 1151-1155; discussion 1155-1156.
24. Burkus JK, Gornet MF, Dickman CA,. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002; 15: 337-349.
25. Cochran DL, Jones AA, Lilly LC,. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000; 71: 1241-1257.
26. Govender S, Csimma C, Genant HK,. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84-A: 2123-2134.
27. Triplett RG, Nevins M, Marx RE,. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009; 67: 1947-1960.
28. Helm GA, Sheehan JM, Sheehan JP,. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 1997; 86: 93-100.
29. Yang XB, Whitaker MJ, Sebald W,. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 2004; 10: 1037-1045.
30. Argintar E, Edwards S, Delahay J,. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2010; 42: 730-734.
31. Boraiah S, Paul O, Hawkes D,. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res 2009; 467: 3257-3262.
32. Shields LB, Raque GH, Glassman SD,. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 2006; 31: 542-547.
33. Seeherman H, Wozney JM,. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005; 16: 329-345.
34. Geiger M, Li RH, Friess W,. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003; 55: 1613-1629.
35. Coulibaly F, Chiu E, Ikeda K,. The molecular organization of cypovirus polyhedra. Nature 2007; 446: 97-101.
36. Matsushima K, Suyama T, Takenaka C,. Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury. Tissue Eng Part A 2010; 16: 3329-3341.